Capstone Investment Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Capstone Investment Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-84,469	Closed	-$4.51M	–	965
2016 Q1	$4.51M	Buy	+84,469	New	+$6.24M	0.14%	109

Other funds holding ANAC

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Capstone Investment Advisors's ANAC Position: Q2 2016 in Review

Capstone Investment Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 84,469 shares — an estimated $4.51M sold.

Capstone Investment Advisors first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $4.51M in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Capstone Investment Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Capstone Investment Advisors sold 84,469 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $4.51M.
Capstone Investment Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
Capstone Investment Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $4.51M in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Capstone Investment Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.